Recent news on Orthovisc

Anika Therapeutics: A Success Story in the Making  -  May 10, 2007
Seeking Alpha,I also like growth potential of ANIK’s Orthovisc franchise, which represented 42% of ANIK’s total 2006 sales and earned 47% gross margin.

Groups differ on how to dispose of medications  -  Apr 27, 2007
Baltimore Sun,The medications, with names like Synvisc, Orthovisc and Hylan G-F20, are supposed to supplement the thick or viscous synovial fluid found in normal knees

Anika Therapeutics Announces Date of First Quarter Fiscal 2007 ...  -  Apr 23, 2007
PharmaLive.com (press release),Anika products include ORTHOVISC(R), a treatment for osteoarthritis of the knee available internationally and marketed in the US by DePuy Mitek,

Anika Therapeutics Announces Date of First Quarter Fiscal 2007 ...  -  Apr 23, 2007
PR-Inside.com (Pressemitteilung),Anika products include ORTHOVISC(R), a treatment for osteoarthritis of the knee available internationally and marketed in the US by DePuy Mitek,

Anika Therapeutics Reports Fourth-Quarter and Full-Year 2006 ...  -  Mar 1, 2007
PharmaLive.com (press release),The increase in domestic sales of ORTHOVISC was partially offset by reduced international sales due to a change in the Turkish government's reimbursement

Market Report -- In Play (ANIK)  -  Mar 1, 2007
MSN MoneyWith a unique reimbursement code for ORTHOVISC, we anticipate US product sales of ORTHOVISC to grow significantly in 2007."

Helix BioPharma Announces Q2 2007 Financial Results  -  Mar 9, 2007
PharmaLive.com (press release),...research expenditures relating to the Company's novel anti-cancer therapeutic, L-DOS47, and reduced revenue forecasts for Orthovisc(R) and assuming no

Helix BioPharma Announces Q2 2007 Financial Results  -  Mar 8, 2007
CNW Telbec (Communiqués de presse),...the sale of Orthovisc(R), as price reductions and increased product sampling of competitive product continued into the second quarter of fiscal 2007.

Smoothing Out the Wrinkles on Anika Therapeutics  -  Feb 11, 2007
Seeking Alpha,Even if Anika has trouble selling their new wrinkle treatment (which seems highly unlikely) they are still experiencing solid growth in their OrthoVisc

Anika Therapeutics Announces Date of Fourth Quarter and Year End ...  -  Feb 16, 2007
PharmaLive.com (press release),Anika products include ORTHOVISC(R), a treatment for osteoarthritis of the knee available internationally and marketed in the US by DePuy Mitek,

Orthovisc Clinical Study Commenced To Expand Usage  -  Jan 9, 2007
PharmaLive.com (press release),..."Our plan for ORTHOVISC in the next few years incorporates several important clinical studies," said Anika President and Chief Executive Officer Charles H.

ORTHOVISC(R) Clinical Study Commenced To Expand Usage  -  Jan 8, 2007
PR Newswire (press release),Study Designed to Determine the Effectiveness of ORTHOVISC in the Treatment of Osteoarthritis of the Shoulder WOBURN, Mass., Jan.

Market Report -- In Play (ANIK)  -  Jan 9, 2007
MSN MoneyAnika Therapeutics says Orthovisc clinical study commenced to expand usage Co and DePuy Mitek amnnounce they have initiated a clinical study designed to

(PRN) - Drew Industries Acquires Two Manufacturers of RV ...  -  Jan 8, 2007
Bolsamania.com,...(PRN) - BCG Named Best Small Company on FORTUNE's '100 Best Companies to Work For' List ... [+]. (PRN) - ORTHOVISC(R) Clinical Study Commenced To Expand

(PRN) - Leading Power System Technology Expert Dr. Gregory Reed ...  -  Jan 8, 2007
Bolsamania.com,...(PRN) - ORTHOVISC(R) Clinical Study Commenced To Expand Usage ... [+]. (PRN) - CHAMCO AUTO Announces Bradley J. Czajka as Vice President of Supply Chain

Anika Therapeutics Receives FDA Approval for Cosmetic Tissue ...  -  Dec 24, 2006
Seeking Alpha,These include, OrthoVisc, a treatment for osteoarthritis of the knee; Hyvisc, a treatment for equine osteoarthritis; and Amvisc and Amvisc Plus,

Anika Therapeutics Receives FDA Approval For Its Cosmetic Tissue ...  -  Dec 23, 2006
Medical News Today (press release),Anika products include ORTHOVISC(R), a treatment for osteoarthritis of the knee available internationally and marketed in the US by DePuy Mitek and

ORTHOVISC(R) Receives Unique Reimbursement Code  -  Dec 17, 2006
Drug Newswire (press release),This move will simplify the current reimbursement process, and improve access to ORTHOVISC, a treatment for osteoarthritis of the knee.

ORTHOVISC(R) Receives Unique Reimbursement Code  -  Dec 15, 2006
Earthtimes.org15 -- Anika Therapeutics, Inc. today announced that its ORTHOVISC(R) product has been assigned a separate reimbursement code by the Centers for Medicare and

Market Report -- In Play (ANIK)  -  Dec 15, 2006
MSN MoneyAnika Therapeutics: Orthovisc receives unique reimbursement code Co announces that it Orthovisc product has been assigned a separate reimbursement code by

Anika shares jump on Medicare move  -  Dec 15, 2006
BusinessWeekOrthovisc is a treatment for osteoarthritis of the knee. The injection was previously grouped with other products in that category made earlier this fall.

Partners HealthCare posts 75% more operating profit  -  Dec 16, 2006
Boston Globe,Anika said the code will improve access to Orthovisc . . . Boston Scientific Corp. said it is recalling about 51 of its Mach 1 Guide Catheters after finding

Baird Comments on Genzyme (GENZ), Saying CMS Reversed Prior ...  -  Dec 15, 2006
StreetInsider.com (subscription),Orthovisc - Synvisc's closest comp in the category - is reimbursed at $200.54/dose, making the economics fairly comparable across the board.

Anika Therapeutics Receives FDA Approval for Cosmetic Tissue ...  -  Dec 24, 2006
Seeking Alpha,These include, OrthoVisc, a treatment for osteoarthritis of the knee; Hyvisc, a treatment for equine osteoarthritis; and Amvisc and Amvisc Plus,

Anika Therapeutics Receives FDA Approval For Its Cosmetic Tissue ...  -  Dec 23, 2006
Medical News Today (press release),Anika products include ORTHOVISC(R), a treatment for osteoarthritis of the knee available internationally and marketed in the US by DePuy Mitek and

Helix Biopharma announces Q1 2007 financial results  -  Dec 13, 2006
CNW Telbec (Communiqués de presse),...research expenditures relating to the Company's novel anti-cancer therapeutic, L-DOS47, and marketing expenditures relating primarily to Orthovisc(R),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional